Edoardo Lenci

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab

Edoardo Lenci, Luca Cantini, Federica Pecci et al. · Journal of Clinical Medicine · 2021 · 45 citations · Full text

Medicine, Immunology, Oncology +17

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer

Alessandro Bittoni, Federica Pecci, Giulia Mentrasti et al. · Annals of Translational Medicine · 2021 · 40 citations · Full text

Medicine, Immunology, Oncology +17

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience

Mirco Pistelli, Valentina Natalucci, Laura Scortichini et al. · Cancers · 2021 · 17 citations · Full text

Medicine, Nutrition, Oncology +12

Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

Francesco Massari, Veronica Mollica, Ondřej Fiala et al. · European Urology Oncology · 2024 · 13 citations · Full text

Medicine, Oncology, Pharmacotherapy +14